Thirty years ago, just three drugs were available for the treatment of viral infections, but now more than forty have been approved. What have been the guiding principles in these achievements and what might the future hold for antiviral drug development? SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nrd2485) contains supplementary material, which is available to authorized users.